NIH-funded research R01 grant

Understanding how HIV-1 assembles and interacts with host cells

Official title: Viral and Cellular Determinants of HIV-1 Assembly

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11090446 · Data updated 2026-11-12

This study is looking at how the HIV virus puts itself together inside our cells and is trying to find new ways to help treat HIV by understanding the role of certain proteins in this process, which could lead to better treatments for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startMay 20, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$609,012
NIH project number5R01AI186611-02
Project IDNIH-11090446 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are seeking innovative treatment options.

Less likely to help

Patients who are not infected with HIV or those who are not responsive to antiretroviral therapies may not benefit from this research.

What this research studies

This research investigates the mechanisms by which HIV-1 assembles infectious particles by examining the interactions between the virus and host cellular pathways. The team has identified specific adaptor proteins, such as Rab11-FIP1C, that are crucial for the trafficking and incorporation of HIV-1 envelope proteins into viral particles. By studying these interactions, the research aims to uncover new components of the recycling machinery that facilitate HIV-1 assembly, which could lead to novel therapeutic strategies. Patients may benefit from insights gained into how HIV-1 operates within the body, potentially informing future treatments.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches that improve treatment outcomes for patients living with HIV.

How similar studies have gone: Previous research has shown success in understanding viral assembly mechanisms, indicating that this approach has the potential for significant advancements.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Spearman, Paul W. — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Spearman, Paul W.

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.